Graviti Pharmaceuticals Private recalls
Graviti Pharmaceuticals Private has 3 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 28 Jan 2026. 2 are still ongoing. 2 were reported in the last 12 months.
Total recalls3since 2020
Last 12 months2reported
Class I00% of total
Ongoing2latest 28 Jan 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why graviti pharmaceuticals private is recalled
Product types
Brands
By year
Ongoing graviti pharmaceuticals private recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Furosemide Tablets, USP 40 mg recalled by Graviti PharmaceuticalsFurosemide | Graviti Pharmaceuticals Private | Other | Nationwide |
| Drug | CLASS II | Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg recalledBupropion Hydrochloride | Graviti Pharmaceuticals Private | Other | Nationwide |
All graviti pharmaceuticals private recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Furosemide Tablets, USP 40 mg recalled by Graviti PharmaceuticalsFurosemide | Graviti Pharmaceuticals Private | Other | Nationwide |
| Drug | CLASS II | Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg recalledBupropion Hydrochloride | Graviti Pharmaceuticals Private | Other | Nationwide |
| Drug | CLASS II | Atorvastatin Calcium Tablets, USP, 10 mg* recalled | Graviti Pharmaceuticals Private | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.